Notice of Change to PAR-20-273, "New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required)"
Notice Number:
NOT-DA-23-035

Key Dates

Release Date:

August 15, 2023

Related Announcements

  • August 28, 2020 - New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required) See Notice PAR-20-273 

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This is a Notice of Correction to the Key Dates information in PAR-20-273 “New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 - Clinical Trial Required) ”

The following section of PAR-20-273  has been corrected:

Part 1. Overview Information

Key Dates

Currently, it reads:

Posted Date

 August 28, 2020

Open Date (Earliest Submission Date)

 October 18, 2020

Letter of Intent Due Date(s)

 Not applicable

Application Due Date(s)

 Only accepting applications for the AIDS Application Due Dates listed below.

AIDS Application Due Date(s)

 November 18, 2020, August 11, 2021, November 18, 2021, August 11, 2022, November 18, 2022, August 11, 2023

Scientific Merit Review

 March 2021,November 2021, March 2022, November 2022, March 2023, November 2023

Advisory Council Review

 May 2021, January 2022, May 2022, January 2023, May 2023, January 2024

Earliest Start Date

 July 2021, March 2022, July 2022, March 2023, July 2023, March 2024

Expiration Date

 New Date July 21, 2023 per issuance of RFA-DA-25-019. (Original Expiration Date: August 12, 2023)

Part 1. Overview Information

Key Dates

Revised to read (in bold italics): 

Posted Date

 August 28, 2020

Open Date (Earliest Submission Date)

 October 18, 2020

Letter of Intent Due Date(s)

 Not applicable

Application Due Date(s)

 Only accepting applications for the AIDS Application Due Dates listed below.

AIDS Application Due Date(s)

 November 18, 2020, August 11, 2021, November 18, 2021, August 11, 2022, November 18, 2022, September 15, 2023 

Scientific Merit Review

 March 2021,November 2021, March 2022, November 2022, March 2023, November 2023

Advisory Council Review

 May 2021, January 2022, May 2022, January 2023, May 2023, January 2024

Earliest Start Date

 July 2021, March 2022, July 2022, March 2023, July 2023, March 2024

Expiration Date

 New Date September 16, 2023 

All other aspects of PAR-20-273 remain unchanged.

Inquiries

Please direct all inquiries to:

Minnjuan Flournoy Floyd, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6474
Email: Minnjuan.flournoyfloyd@nih.gov